pipette
ESEspañol

A multimodal arrayed Perturb-seq platform for dissecting microglial state dynamics and target identification

L. Ju, M. C. LaBranche, S. Hromadka, J. Li, Y. D. Kwak, X. Chen, J. Yu, B. Sukumaran, K. A. Worringer, C. Freyre, J. S. Hsiao

Preprint

In the authors' words

Microglia are highly dynamic immune cells of the central nervous system that can adopt diverse functional states in health and disease, making them both emerging therapeutic targets and challenging systems for target identification. Here, we developed TF-iMG, a human pluripotent stem cell-derived transcription factor-induced microglia model generated by inducible expression of SPI1 and CEBPA in Cas9-expressing stem cells. TF-iMG rapidly acquired microglia-like transcriptomic, morphological, inflammatory, and phagocytic features while remaining compatible with efficient lentiviral CRISPR knockout workflows that can be completed within one week. We next established an arrayed multimodal Perturb-seq platform that integrates lentiviral CRISPR knockout, multiplexed single-cell RNA sequencing, cytokine profiling, and live-cell imaging. Single-cell analysis showed that TF-iMG recapitulates intrinsic microglial heterogeneity and captures homeostatic, activated, inflammatory, and proliferative signatures. Stimulation with IL1B and IL4 reproducibly induced distinct pro-inflammatory and anti-inflammatory states, respectively, providing a framework for perturbation-based interrogation of microglial state regulation. Targeting IL1B and IL4 pathway components validated the platform by attenuating expected stimulus-driven state shifts. Profiling of putative microglial regulators and Alzheimer's disease-associated genes further revealed perturbation-specific transcriptional signatures, altered state occupancy, and multimodal phenotypes spanning cytokine release, morphology, and trajectory. Together, this platform enables scalable target identification in microglia.

Main resultThe abstract does not state a limitation.

Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.16.767105